PortfoliosLab logoPortfoliosLab logo
TPST vs. TENX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TPST vs. TENX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tempest Therapeutics, Inc. (TPST) and Tenax Therapeutics, Inc. (TENX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TPST achieves a -56.27% return, which is significantly lower than TENX's 11.89% return. Both investments have delivered pretty close results over the past 10 years, with TPST having a -60.83% annualized return and TENX not far ahead at -58.09%.


TPST

1D
0.40%
1M
-32.53%
YTD
-56.27%
6M
-58.72%
1Y
-81.68%
3Y*
-56.83%
5Y*
-64.36%
10Y*
-60.83%

TENX

1D
11.35%
1M
12.45%
YTD
11.89%
6M
14.05%
1Y
142.70%
3Y*
-17.98%
5Y*
-66.73%
10Y*
-58.09%
*Multi-year figures are annualized to reflect compound growth (CAGR)

TPST vs. TENX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
TPST
Tempest Therapeutics, Inc.
-56.27%-73.54%-81.03%282.61%-78.22%-83.55%-68.25%-15.22%-62.14%-8.50%
TENX
Tenax Therapeutics, Inc.
11.89%96.93%-71.82%-87.67%-89.29%-44.09%31.91%16.53%-87.65%-74.87%

Correlation

The correlation between TPST and TENX is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.09

Correlation (3Y)
Calculated over the trailing 3-year period

0.08

Correlation (5Y)
Calculated over the trailing 5-year period

0.11

Correlation (10Y)
Calculated over the trailing 10-year period

0.10

Correlation (All Time)
Calculated using the full available price history since Nov 12, 2012

0.10

Fundamentals

Market Cap

TPST:

$13.72M

TENX:

$616.89M

EPS

TPST:

-$7.39

TENX:

-$1.41

PB Ratio

TPST:

16.69

TENX:

5.38

Total Revenue (TTM)

TPST:

$0.00

TENX:

$0.00

Gross Profit (TTM)

TPST:

-$22.25M

TENX:

$0.00

EBITDA (TTM)

TPST:

-$42.88M

TENX:

-$42.19M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Tempest Therapeutics, Inc.

Tenax Therapeutics, Inc.

Often compared with TPST:
TPST vs. QQQ

Return for Risk

TPST vs. TENX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TPST
TPST Risk / Return Rank: 88
Overall Rank
TPST Sharpe Ratio Rank: 1010
Sharpe Ratio Rank
TPST Sortino Ratio Rank: 77
Sortino Ratio Rank
TPST Omega Ratio Rank: 66
Omega Ratio Rank
TPST Calmar Ratio Rank: 66
Calmar Ratio Rank
TPST Martin Ratio Rank: 1111
Martin Ratio Rank

TENX
TENX Risk / Return Rank: 8787
Overall Rank
TENX Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
TENX Sortino Ratio Rank: 8888
Sortino Ratio Rank
TENX Omega Ratio Rank: 8787
Omega Ratio Rank
TENX Calmar Ratio Rank: 8686
Calmar Ratio Rank
TENX Martin Ratio Rank: 8383
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TPST vs. TENX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tempest Therapeutics, Inc. (TPST) and Tenax Therapeutics, Inc. (TENX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


TPSTTENXDifference
Sharpe ratioReturn per unit of total volatility

-2.84

Sortino ratioReturn per unit of downside risk

-4.30

Omega ratioGain probability vs. loss probability

0.80

1.37

-0.57

Calmar ratioReturn relative to maximum drawdown

-0.91

3.39

-4.31

Martin ratioReturn relative to average drawdown

-1.31

7.23

-8.55

TPST vs. TENX - Sharpe Ratio Comparison

The current TPST Sharpe Ratio is -0.80, which is lower than the TENX Sharpe Ratio of 2.04. The chart below compares the historical Sharpe Ratios of TPST and TENX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

TPST vs. TENX - Drawdown Comparison

The maximum TPST drawdown since its inception was -100.00%, roughly equal to the maximum TENX drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for TPST and TENX.


Loading charts...

Drawdown Indicators


TPSTTENXDifference

Max Drawdown

Largest peak-to-trough decline

-100.00%

-100.00%

0.00%

Max Drawdown (1Y)

Largest decline over 1 year

-89.60%

-42.31%

-47.29%

Max Drawdown (3Y)

Largest decline over 3 years

-99.03%

-94.42%

-4.61%

Max Drawdown (5Y)

Largest decline over 5 years

-99.61%

-99.92%

+0.31%

Max Drawdown (10Y)

Largest decline over 10 years

-100.00%

-100.00%

0.00%

Current Drawdown

Current decline from peak

-100.00%

-100.00%

0.00%

Average Drawdown

Average peak-to-trough decline

-82.91%

-87.57%

+4.66%

Ulcer Index

Depth and duration of drawdowns from previous peaks

62.11%

19.81%

+42.30%

Volatility

TPST vs. TENX - Volatility Comparison

Tempest Therapeutics, Inc. (TPST) and Tenax Therapeutics, Inc. (TENX) have volatilities of 17.56% and 18.12%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TPSTTENXDifference

Volatility (1M)

Calculated over the trailing 1-month period

17.56%

18.12%

-0.56%

Volatility (6M)

Calculated over the trailing 6-month period

62.02%

60.62%

+1.40%

Volatility (1Y)

Calculated over the trailing 1-year period

102.55%

70.29%

+32.26%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

1,785.03%

165.33%

+1,619.70%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

1,262.90%

144.06%

+1,118.84%

Dividends

TPST vs. TENX - Dividend Comparison

Neither TPST nor TENX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

TPST vs. TENX - Financials Comparison

This section allows you to compare key financial metrics between Tempest Therapeutics, Inc. and Tenax Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002022202320242025202600
(TPST) Total Revenue
(TENX) Total Revenue
Values in USD except per share items

Frequently Asked Questions


TPST and TENX have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TENX has higher volatility (18.12%) compared to TPST (17.56%). In terms of maximum drawdown, TPST dropped -100.00% vs TENX's -100.00%.

TENX currently has the higher Sharpe Ratio (2.04 vs -0.80), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TPST and TENX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer